Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Continuous Versus Intermittent Linezolid Infusion in Critically Ill Patients With Septic Shock

NCT05813951 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05813951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05813951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Continuous Versus Intermittent Linezolid Infusion in Critically Ill Patients With Septic Shock
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Unknown status
Start date
December 2, 2022
Completion date
December 2, 2023
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment efficacy